WHO ICTRP trial
A randomized, double blind, placebo-controlled, double dummy, three-way…
NL-OMON31294 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON31294 |
|---|---|
| Public title | A randomized, double blind, placebo-controlled, double dummy, three-way crossover study to investigate the effects of an intravenous ethanol clamp and a morphine infusion on resting state functional magnetic resonance imaging in healthy male volunteers |
| Scientific title | A randomized, double blind, placebo-controlled, double dummy, three-way crossover study to investigate the effects of an intravenous ethanol clamp and a morphine infusion on resting state functional magnetic resonance imaging in healthy male volunteers - Effects of ethanol and morphine on fMRI |
| Primary sponsor | Centre for Human Drug Research |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Er zal bij deze studie niet gekeken worden naar de aandoening die het middel behandelt. De farmacodynamische effecten van morfine/ethanol op resting state networks in de hersenen zullen worden bestudeerd. not applicable;not applicable |
| Interventions | Ethanol 10% w/v solution in 5% glucose will be delivered by intravenous infusion to maintain blood ethanol concentration near 0.60 g/L for 150 minutes. The target concentration of 0.60 g/L is expected to be well tolerated, since this… |
| Registration date | Aug 13, 2007 |
| Target size | 12 |
| Secondary IDs | 2007-001593-93;NL17581.058.07 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: